Trump administration moves forward with certain drug reclassifications
Summary
President Donald Trump signed an executive order to support more research into using psychedelic drugs to treat some mental illnesses. This follows his earlier decision in December 2025 to lower the drug classification of marijuana, making it considered less dangerous.Key Facts
- President Trump signed an executive order on Saturday about drug research.
- The order encourages studying psychedelics for mental health treatments.
- In December 2025, President Trump reclassified marijuana as a less dangerous drug.
- Reclassifying a drug changes how it is viewed and regulated by the government.
- The moves aim to make it easier for scientists to study these substances.
- Josh Kesselman, founder of RAW rolling papers and publisher of High Times Magazine, is mentioned in relation to these changes.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
